Novavax, Inc. Price Today
Novavax, Inc.
NVAX
Healthcare
$695.62M
💰
Market Cap
0
💸
Price to Earnings
$-14.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
1 |
Strong Buy |
1 |
Hold |
5 |
Sell |
3 |
Strong Sell |
2 |
NVAX Price Forecast Target
8.1 👉 41.0 +409%
NVAX EPS Forecast
-14.9 👉 -1.8 +-88%
Financials
Profit Margin
-85 %
Revenue Growth
-88.5 %
Dividend
$ 0
Held Percent
0.6% - Insiders
70.6% - Institutions
28.8% - Public
Major Fund Holders
-
💰 State Street Corporation $76.9M
-
💰 Vanguard Group Inc $70.6M
-
💰 Shah Capital Management $40.7M
-
💰 Blackrock Inc. $33.1M
-
💰 Renaissance Technologies, LLC $24.5M
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…📮FAQ
Some Frequently Asked Questions.
The Novavax, Inc. industry is Biotechnology
The Novavax, Inc. sector is Healthcare
The Novavax, Inc. forecasted predicted Price to Earnings PE ratio is -4.5
The Novavax, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Novavax, Inc. is $695.62M
There are total of 80418215 float shares with 70.6% held by Institutions and 0.6% held by insiders
The MNovavax, Inc. forecasted Earnings per Share EPS is $-1.8
The Novavax, Inc. Earnings per Share EPS is -14.9
The Novavax, Inc. company has $-156045000 gross profits with -85 profit margins
The Novavax, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Novavax, Inc. Revenue is $1358851968 with -0.885 revenue growth
The price target for Novavax, Inc. stock is $41.0 for the high target and $9.0 for the low target
The consensus analyst recommendations for Novavax, Inc. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novavax, Inc. is Hold, with the following breakdown:
- Buy: 1
- Strong Buy: 1
- Hold: 5
- Sell: 3
- Strong Sell: 2
The Beta of Novavax, Inc. is 1.7
The dividend of Novavax, Inc. is $0
The dividend yield of Novavax, Inc. is 0%
The biggest institutional and mutual fund holders of Novavax, Inc. stock are
- State Street Corporation
- Vanguard Group Inc
- Shah Capital Management
- Blackrock Inc.
The Novavax, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0